• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    Allergan plc (AGN)

    -NYSE
    216.56 Down 2.29(1.05%) 4:01PM EDT
    |After Hours : 216.50 Down 0.06 (0.03%) 6:49PM EDT - Nasdaq Real Time Price
    ProfileGet Profile for:
    Allergan plc
    Morris Corporate Center III
    400 Interpace Parkway
    Parsippany, NJ 07054
    United States - Map
    Phone: 862-261-7000
    Website: http://www.allergan.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drugs - Generic
    Full Time Employees:31,200

    Business Summary 

    Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women’s health and urology, ophthalmology, neurosciences, and medical aesthetics, as well as dermatology and plastic surgery. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. Allergan plc also distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians’ offices. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Parsippany, New Jersey.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Allergan plc

    Corporate Governance 
    Allergan plc’s ISS Governance QuickScore as of Apr 1, 2016 is 9. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 5; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Paul M. Bisaro , 55
    Exec. Chairman
    18.95M0.00
    Mr. Brenton L. Saunders J.D., 46
    Chief Exec. Officer, Pres and Director
    21.56M0.00
    Ms. Maria Teresa Hilado , 51
    Chief Financial Officer and Exec. VP
    9.23M0.00
    Mr. Robert A. Stewart , 48
    Exec. VP and Pres of Generic & Global Operations
    9.60M0.00
    Mr. William Meury , 47
    Exec. VP and Pres of Branded Pharma
    6.36M0.00
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders